Cargando…
Can use of the serum anti-PLA(2)R antibody negate the need for a renal biopsy in primary membranous nephropathy?
BACKGROUND: Since the emergence of the anti-PLA(2)R antibody (PLA(2)R-Ab) test, nephrology practice has not changed dramatically, with most nephrologists still relying on a kidney biopsy to diagnose membranous nephropathy. In this study, we examined the clinical accuracy of the anti-PLA(2)R antibody...
Autores principales: | Ragy, Omar, Rautemaa, Vilma, Smith, Alison, Brenchley, Paul, Kanigicherla, Durga, Hamilton, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955960/ https://www.ncbi.nlm.nih.gov/pubmed/36827283 http://dx.doi.org/10.1371/journal.pone.0281726 |
Ejemplares similares
-
PLA2R Antibody Does Not Outperform Conventional Clinical Markers in Predicting Outcomes in Membranous Nephropathy
por: Ragy, Omar, et al.
Publicado: (2023) -
Long-Term Safety, Clinical and Immunological Outcomes in Primary Membranous Nephropathy with Severe Renal Impairment Treated with Cyclophosphamide and Steroid-Based Regimen
por: Ragy, Omar, et al.
Publicado: (2023) -
The investigative burden of membranous nephropathy in the UK
por: Hamilton, Patrick, et al.
Publicado: (2019) -
Membranous nephropathy in the UK Biobank
por: Hamilton, Patrick, et al.
Publicado: (2023) -
Thromboembolism in nephrotic syndrome: controversies and uncertainties
por: Parker, Kathrine, et al.
Publicado: (2023)